pimobendan has been researched along with Cardiotoxicity in 1 studies
pimobendan: produces arterial & venous dilatation in dogs; structure given in first source
Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cardiovascular adverse effects in drug development are a major source of compound attrition." | 1.62 | An Integrative Approach for Improved Assessment of Cardiovascular Safety Data. ( Gabrielsson, J; Jirstrand, M; Martel, E; Pairet, N; Scheuerer, S; Wallman, M, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wallman, M | 1 |
| Scheuerer, S | 1 |
| Martel, E | 1 |
| Pairet, N | 1 |
| Jirstrand, M | 1 |
| Gabrielsson, J | 1 |
1 other study available for pimobendan and Cardiotoxicity
| Article | Year |
|---|---|
An Integrative Approach for Improved Assessment of Cardiovascular Safety Data.
Topics: Animals; Biomarkers, Pharmacological; Blood Pressure; Cardiotoxicity; Cardiovascular Agents; Heart R | 2021 |